[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338932-105":59,"doc-detail-338932-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-quest-for-nanoparticle-powered-vaccines-in-cancer-immunotherapy","The quest for nanoparticle-powered vaccines in cancer immunotherapy","","Despite major advances in cancer therapy, cancer remains a serious public-health threat. Vaccines help prevent disease by coordinating adaptive and innate immune responses, and growing knowledge of malignancies and immunity has driven interest in priming the immune system against tumors. This review focuses on nanoparticle systems for antigen delivery, summarizing immunological mechanisms and highlighting recent nanoparticle applications, while outlining challenges and barriers to clinical feasibility and future, more effective targeted immunotherapies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-quest-for-nanoparticle-powered-vaccines-in-cancer-immunotherapy/338932/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-quest-for-nanoparticle-powered-vaccines-in-cancer-immunotherapy/338932.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are vaccines important in cancer immunotherapy?","Question",{"text":113,"@type":114},"Vaccines stimulate immune responses and can activate immunity against tumor cells, supporting both therapeutic and preventive cancer vaccination strategies.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What role do nanoparticle systems play in these vaccines?",{"text":118,"@type":114},"Nanoparticle platforms are used for antigen delivery and have been shown to potentiate immune responses, acting as vaccines and/or adjuvants.",{"name":120,"@type":111,"acceptedAnswer":121},"What limitations of current cancer vaccines does the review address?",{"text":122,"@type":114},"Many current vaccines cannot elicit sufficiently robust immune responses against cancer cells, motivating strategies such as peptide-, DNA-, protein-, and dendritic cell-based approaches.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338932,1790143781,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Sun et al. Journal of Nanobiotechnology (2024) 22:61  \n[https://doi.org/10.1186/s12951-024-02311-z](https://doi.org/10.1186/s12951-024-02311-z)  \nJournal of Nanobiotechnology  \n REVIEW Open Access  \nThe quest for nanoparticle-powered vaccines in cancer immunotherapy  \nZhe Sun1†, Hui Zhao2†, Li Ma1, Yanli Shi1, Mei Ji1, Xiaodong Sun3, Dan Ma1, Wei Zhou1, Tao Huang4* and Dongsheng Zhang1*  \nAbstract  \nDespite recent advancements in cancer treatment, this disease still poses a serious threat to public health.  \nVaccines play an important role in preventing illness by preparing the body’s adaptive and innate immune responses to combat diseases. As our understanding of malignancies and their connection to the immune system improves, there has been a growing interest in priming the immune system to fight malignancies more effectively and comprehensively. One promising approach involves utilizing nanoparticle systems for antigen delivery, which has been shown to potentiate immune responses as vaccines and/or adjuvants. In this review, we comprehensively summarized the immunological mechanisms of cancer vaccines while focusing specifically on the recent applications of various types of nanoparticles in the field of cancer immunotherapy. By exploring these recent breakthroughs, we hope to identify significant challenges and obstacles in making nanoparticle-based vaccines and adjuvants feasible for clinical application. This review serves to assess recent breakthroughs in nanoparticle-based cancer vaccinationsand shed light on their prospects and potential barriers. By doing so, we aim to inspire future immunotherapies for cancer that harness the potential of nanotechnology to deliver more effective and targeted treatments.  \nKeywords Nanoparticles, Immunotherapy, Cancer, Adjuvants, Innate immunity, Humoral immunity, Antigen  \n†Zhe Sun and Hui Zhao contributed equally to this work and should be considered co-first authors.  \n*Correspondence: Tao Huang [tao.huang@unimelb.edu.au](tao.huang@unimelb.edu.au)[ ](tao.huang@unimelb.edu.au)Dongsheng Zhang [ds63zhang@sdu.edu.cn](ds63zhang@sdu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativeco](http://creativeco)[mmons.org/publicdomain/zero/1.0/](mmons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nSun et al. Journal of Nanobiotechnology (2024) 22:61 Page 2 of 36  \nGraphical abstract  \nIntroduction  \nVaccines stand as one of the most crucial tools for protecting people from infectious diseases and cancers [1–6]. Since Edward Jenner discovered the first vaccine (derived from the Orthopoxvirus cowpox species) to trigger protective immune responses against smallpox ( Vaccinia virus) in 1796, significant progress has been made on vaccines development t","cbCaipmUcS8sulsa","https://ap.wps.com/l/cbCaipmUcS8sulsa","pdf",6163857,36,"English","# Abstract\n# Introduction","[{\"question\":\"Why are vaccines important in cancer immunotherapy?\",\"answer\":\"Vaccines stimulate immune responses and can activate immunity against tumor cells, supporting both therapeutic and preventive cancer vaccination strategies.\"},{\"question\":\"What role do nanoparticle systems play in these vaccines?\",\"answer\":\"Nanoparticle platforms are used for antigen delivery and have been shown to potentiate immune responses, acting as vaccines and/or adjuvants.\"},{\"question\":\"What limitations of current cancer vaccines does the review address?\",\"answer\":\"Many current vaccines cannot elicit sufficiently robust immune responses against cancer cells, motivating strategies such as peptide-, DNA-, protein-, and dendritic cell-based approaches.\"}]","The quest for nanoparticle-powered vaccines in cancer immunotherapy | PDF",1790026617,91,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5246d438b643582bd5e03206c5ff499.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d50ee53aa9baa85f19842e88a27a7081.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2dbf22f33761da5ef04bb02e5d30279b.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69f730314a00a132b4efdc17a8f61b72.webp",980,1301]